Capsid inhibitors for the treatment of HIV
US11680064B2 · kind B2 · utility
7Cited by
43References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2021 |
| Grant date | Jun 20, 2023 |
| Priority date | — |
| Expiry date | Jun 24, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to certain compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions disclosed herein may be used for the treatment or prevention of a Retroviridae viral infection, including an infection caused by the HIV virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.